Literature DB >> 10469456

Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.

H Nishiyama1, T Takahashi, Y Kakehi, T Habuchi, M A Knowles.   

Abstract

Loss of heterozygosity (LOH) on chromosome arm 9q is the most frequent genetic alteration found in superficial and invasive transitional cell carcinoma (TCC) in a previous microsatellite-based deletion mapping study of the bladder and upper urinary tract, indicating the presence of one or more important tumor suppressor genes (TSGs). One of the putative tumor suppressor loci on 9q (DBC1) was mapped to 9q32-33 and the candidate region was localized within a single YAC. We report here a case of superficial papillary TCC, which showed a homozygous deletion encompassing this candidate tumor suppressor region. The region of homozygous deletion spanned the interval between D9S275 and AFMA239XA9 at 9q32-33, and was estimated to be </=6 cM. Although homozygous deletion mapping did not narrow down the candidate tumor suppressor region, this case provides further support for the presence of a TSG for TCC in this chromosomal region. To our knowledge, this is the first report to show homozygous deletion at 9q32-33 in TCC or any other type of human tumor. Genes Chromosomes Cancer 26:171-175, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469456

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.

Authors:  Christine L Chaffer; Bonnie Dopheide; Daniel R McCulloch; Allan B Lee; Jane M Moseley; Erik W Thompson; Elizabeth D Williams
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure.

Authors:  Shawn M Wnek; Taylor J Jensen; Paul L Severson; Bernard W Futscher; A Jay Gandolfi
Journal:  Toxicol Sci       Date:  2010-04-07       Impact factor: 4.849

Review 3.  Molecular pathogenesis of bladder cancer.

Authors:  Margaret A Knowles
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

4.  Long Non-Coding RNA NEAT1 Promoted Hepatocellular Carcinoma Cell Proliferation and Reduced Apoptosis Through the Regulation of Let-7b-IGF-1R Axis.

Authors:  Qin Liu; Hexian Shi; Jianbo Yang; Ning Jiang
Journal:  Onco Targets Ther       Date:  2019-11-29       Impact factor: 4.147

5.  Chromosomal changes in uroepithelial carcinomas.

Authors:  Imad Fadl-Elmula
Journal:  Cell Chromosome       Date:  2005-08-07

6.  Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder.

Authors:  F Kimura; A R Florl; H H Seifert; J Louhelainen; S Maas; M A Knowles; W A Schulz
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

Review 7.  SLC14A1: a novel target for human urothelial cancer.

Authors:  R Hou; X Kong; B Yang; Y Xie; G Chen
Journal:  Clin Transl Oncol       Date:  2017-06-06       Impact factor: 3.405

8.  Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma.

Authors:  S Gao; J Worm; P Guldberg; H Eiberg; A Krogdahl; J A Sørensen; C-J Liu; J Reibel; E Dabelsteen
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.